Eva Nelson - BioGaia AB Co Mang

BIOG-B Stock  SEK 105.80  1.10  1.05%   

Insider

Eva Nelson is Co Mang of BioGaia AB
Phone46 8 55 52 93 00
Webhttps://www.biogaia.com

BioGaia AB Management Efficiency

The company has return on total asset (ROA) of 0.1041 % which means that it generated a profit of $0.1041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1941 %, meaning that it generated $0.1941 on every $100 dollars invested by stockholders. BioGaia AB's management efficiency ratios could be used to measure how well BioGaia AB manages its routine affairs as well as how well it operates its assets and liabilities.
BioGaia AB has accumulated 10.4 M in total debt with debt to equity ratio (D/E) of 4.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioGaia AB has a current ratio of 3.63, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BioGaia AB until it has trouble settling it off, either with new capital or with free cash flow. So, BioGaia AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioGaia AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioGaia to invest in growth at high rates of return. When we think about BioGaia AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Peter sbergMidsona AB
57
Tobias AntiusNovotek AB
51
Marjolaine CevozGoyatMidsona AB
N/A
Antti MPNovotek AB
45
Tora MolanderMidsona AB
45
Ulrika PalmMidsona AB
50
Max BokanderMidsona AB
50
Emelie GozziC Rad AB
N/A
John AndersonStille AB
48
Erk SchuchhardtMidsona AB
N/A
Ivan AstralagaC Rad AB
N/A
Veronika GrozdanovskaNovotek AB
53
Hanna WilkmanStille AB
56
Tobias TranebornMidsona AB
48
Priscilla KazumbaC Rad AB
N/A
Hakan AxelssonC Rad AB
55
Lars LevinC Rad AB
52
Tim ThurnC Rad AB
42
Niklas CarlnStille AB
49
Xiaodong WangC Rad AB
44
Helena BramstorpNovotek AB
41
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people. BioGaia AB (BIOG-B) is traded on Stockholm Exchange in Sweden and employs 212 people.

Management Performance

BioGaia AB Leadership Team

Elected by the shareholders, the BioGaia AB's board of directors comprises two types of representatives: BioGaia AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioGaia. The board's role is to monitor BioGaia AB's management team and ensure that shareholders' interests are well served. BioGaia AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioGaia AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gianfranco Grompone, Chief RD
Eva Nelson, Co Mang
Sebastian Heimfors, VP Officer
MBA Econ, Founder Chairman
Isabelle Ducellier, CEO Pres
Marika Isberg, Regulatory Legal
Angelika Kjelldorff, VP HR
Linda Hagglund, VP Marketing
Alexander M, Ex CFO
Jens Velling, Chief Officer

BioGaia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioGaia AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in BioGaia Stock

BioGaia AB financial ratios help investors to determine whether BioGaia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioGaia with respect to the benefits of owning BioGaia AB security.